Cytometry Part B-Clinical Cytometry

Papers
(The TQCC of Cytometry Part B-Clinical Cytometry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
CD34 and CD117 negative pure erythroid leukemia and phenotypic differences with acute megakaryoblastic leukemia24
BCR::ABL1 fusion gene positive de novo acute myeloid leukemia with coexistence of NRAS mutation and presented with a peculiar CD58 positive immunophenotype21
CD62‐L down‐regulation after L18‐MDP stimulation as a complementary flow cytometry functional assay for the diagnosis of XIAP deficiency20
19
CLL/SLL specifically binding to the APC fluorochrome: A previously undescribed phenomenon17
Issue Information16
Prognostic significance of hematogone presence after autologous stem cell transplantation in patients with multiple myeloma15
Flow cytometry in the diagnosis of myelodysplastic syndromes15
Editor's response to Bunting et al.15
Issue Information13
The use of erythrocytes as biomarkers with a timeline12
9
An unusual case of cytoplasmic CD3 expressing BPDCN supporting the T‐lineage origin of plasmacytoid dendritic cells9
Dual peaks on flow cytometric DNA ploidy analysis in chronic lymphocytic leukemia with Richter transformation9
Partial recapitulation of fetal thymic T‐cell constitution postnatally in a patient with cartilage hair hypoplasia‐anauxetic dysplasia spectrum disorder: A case report9
Issue Information9
CD69flow cytometry to complement interferon‐γrelease assay for active tuberculosis9
Issue Highlights—July 20218
8
Issue Information8
Issue highlights—May 20237
Acquired RUNX1::CBFA2T2 fusion at extramedullary relapse in a patient of PDGFRA rearranged acute myeloid leukemia post allogenic HSCT7
Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia7
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring7
7
TRBC1 in flow cytometry: Assay development, validation, and reporting considerations7
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms7
Issue highlights—November 20236
Deciphering stage 0 hematogones by flow cytometry in follow‐up bone marrow samples of pediatric B—Acute lymphoblastic leukemia cases: A potential mimicker of residual disease after anti CD19 therapy6
Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact6
MAGIC‐DR: An interpretable machine‐learning guided approach for acute myeloid leukemia measurable residual disease analysis6
Automation in flow cytometry: Guidelines and review of systems6
Detection of CAR‐T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories6
Issue Information6
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry5
Focus on the Holdrinet index: Toward blast quantification by flow cytometry5
Correction to “Flow cytometry to detect bone marrow involvement by follicular lymphoma”5
5
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells5
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder5
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor 5
Immunophenotypic assessment ofPNHclones in major and minor cell lineages in the peripheral blood of patients with paroxysmal nocturnal hemoglobinuria5
Issue highlights—January 20255
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease5
An alternative processing approach to increase CD138 intensity in flow cytometric analysis of plasma cells4
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients4
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di4
4
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience4
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience4
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds3
cyTRBC1 evaluation rapidly identifies sCD3‐negative peripheral T‐cell lymphomas and reveals a novel type of sCD3‐negative T‐cell clone with uncertain significance3
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring3
Issue Information3
3
IgE‐mediated bleomycin hypersensitivity: Evidence from drug‐reactive T lymphocytes3
Dysplastic agranular basophils identified by flow cytometry3
3
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies3
Issue Highlights—May 20223
Issue highlights—November 20223
Standardization of flow cytometric detection of antigen expression3
Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contrib3
Issue highlights—September 20233
A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediasti3
3
3
0.075087070465088